Opolentisima, Alfredo .
HRN: 28-41-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/14/2026
01/21/2026
IV
600mg
Q8h
Diabetic Foot, Left
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes